Close Menu

NEW YORK ─ Bio-Techne on Monday announced that Humana, a Medicare Advantage provider, has awarded a contract effective April 1 for coverage of its ExoDx Prostate (EPI) test for men performed at its Exosome Diagnostics laboratory.

Minneapolis, Minnesota-based Bio-Techne noted that Humana serves an estimated 20 million patients in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.